Pharmacological Treatment of Osteoporosis in Elderly People: A Systematic Review and Meta-Analysis.

Author: ChenRong, DingNa, DongYi-He, LiuHong, LiuShu-Ying, OuYang-Na, ShengZhi-Feng, WangQin-Yi, WenZhang-Xin

Paper Details 
Original Abstract of the Article :
BACKGROUND: The evidence supporting the use of antiresorptive and anabolic agents for fracture prevention in elderly patients is still inconclusive. Whether it is too late to alter the course of the disease in this age-group has remained uncertain. OBJECTIVES: The objective of this study was to det...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000514449

データ提供:米国国立医学図書館(NLM)

Pharmacological Treatment of Osteoporosis in Elderly People: A Systematic Review and Meta-Analysis

Osteoporosis, a condition characterized by weakened bones, is a significant concern for older adults. This research examines the efficacy and safety of antiresorptive and anabolic agents in preventing fractures in elderly patients. The authors conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) and post hoc analyses of RCTs, concluding that both antiresorptive and anabolic agents represent potentially important osteoporosis treatments, showing significant effects on reducing vertebral, nonvertebral, or hip fracture risk, and were well-tolerated by elderly patients.

Treating Osteoporosis in the Elderly: A Focus on Fracture Prevention

The study's findings provide evidence for the effectiveness of antiresorptive and anabolic agents in reducing the risk of fractures in elderly patients with osteoporosis. The meta-analysis of 12 studies demonstrated significant reductions in the incidence of vertebral, nonvertebral, and hip fractures in patients treated with these agents compared to those receiving placebo. This research underscores the importance of pharmacological interventions for osteoporosis prevention in the elderly.

Maintaining Bone Health in Later Life: A Lifelong Journey

Maintaining bone health throughout life is crucial for preventing osteoporosis and fractures, particularly in later life. This research highlights the importance of early intervention and the potential benefits of pharmacological treatments like antiresorptive and anabolic agents in managing osteoporosis in the elderly. The findings emphasize the need for a comprehensive approach to bone health, incorporating lifestyle modifications, nutrition, and appropriate medical management.

Dr. Camel's Conclusion

Just as a camel's hump provides a reserve of energy for long journeys, strong bones are essential for maintaining mobility and independence in later life. This research, like a well-worn desert path, guides us towards better understanding and treating osteoporosis in the elderly, helping them to navigate the challenges of aging with greater strength and resilience.

Date :
  1. Date Completed 2022-02-28
  2. Date Revised 2022-02-28
Further Info :

Pubmed ID

33823511

DOI: Digital Object Identifier

10.1159/000514449

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.